Drug Profile
Carbamazepine controlled release
Alternative Names: Bipotrol; Carbamazepine - bipolar disorder; Carbatrol; Equetro; SPD-417Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Shire Pharmaceuticals Group
- Developer Takeda
- Class Antidepressants; Antiepileptic drugs; Antimanics; Dibenzazepines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bipolar disorders; Epilepsy
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 12 Jan 2012 Generic equivalent available in USA
- 19 Apr 2005 First global launch of Carbamazepine controlled release for Bipolar disorders in USA (PO; capsules)